Ciliary Ion Channels in Polycystic Kidney Disease
Cells · 2025
DOI: 10.3390/cells14060459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Lubna A Alshriem und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA. Hauptthemen laut MEDLINE: Cilia, Polycystic Kidney Diseases, Ion Channels. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, American Foundation of Pharmaceutical Education (AFPE) Gateway.
Abstract (Originalsprache)
Polycystic kidney disease (PKD) is the most common hereditary disorder that disrupts renal function and frequently progresses to end-stage renal disease. Recent advances have elucidated the critical role of primary cilia and ciliary ion channels, including transient receptor potential (TRP) channels, cystic fibrosis transmembrane conductance regulator (CFTR), and polycystin channels, in the pathogenesis of PKD. While some channels primarily function as chloride conductance channels (e.g., CFTR), others primarily regulate calcium (Ca+2) homeostasis. These ion channels are essential for cellular signaling and maintaining the normal kidney architecture. Dysregulation of these pathways due to genetic mutations in PKD1 and PKD2 leads to disrupted Ca+2 and cAMP signaling, aberrant fluid secretion, and uncontrolled cellular proliferation, resulting in tubular cystogenesis. Understanding the molecular mechanisms underlying these dysfunctions has opened the door for innovative therapeutic strategies, including TRPV4 activators, CFTR inhibitors, and calcimimetics, to mitigate cyst growth and preserve renal function. This review summarizes the current knowledge on the roles of ciliary ion channels in PKD pathophysiology, highlights therapeutic interventions targeting these channels, and identifies future research directions for improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.
ORCID-Profile: Lubna A Alshriem, Wissam AbouAlaiwi
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- American Foundation of Pharmaceutical Education (AFPE) Gateway
- University of Toledo Office of Research and Sponsored Programs
- Alzheimer’s Association
- NIA
- NHLBI
Zitieren
APA
Alshriem, L. A., Buqaileh, R., Alorjani, Q., & AbouAlaiwi, W. (2025). Ciliary Ion Channels in Polycystic Kidney Disease. Cells. https://doi.org/10.3390/cells14060459
Vancouver
Alshriem LA, Buqaileh R, Alorjani Q, AbouAlaiwi W. Ciliary Ion Channels in Polycystic Kidney Disease. Cells. 2025. doi:10.3390/cells14060459
BibTeX
@article{Alshriem2025,
author = {Alshriem, Lubna A and Buqaileh, Raghad and Alorjani, Qasim and AbouAlaiwi, Wissam},
title = {Ciliary Ion Channels in Polycystic Kidney Disease},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14060459}
}
EUVIMED